WLN-68336-36435 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-15
Registered in v-safe
2021-01-15
Dose 2 — Pfizer-BioNTech
2021-01-15
Health check-in — day 0, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Redness · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-29
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-05
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-12
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-26
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-17
Survey response — 3 months, dose 2
MedDRA: Infertility, Rhinovirus infection — Feeling: Good

Free text: Had rhinovirus (lasted 9 days), resolved. Been trying to conceive unsuccessfully for last 3 months.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-18
Survey response — 12 months, dose 2
MedDRA: Complication of pregnancy, Gestational diabetes, Pre-eclampsia, Premature delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Pregnancy, delivered at 34 weeks on 12/1/21. Complicated by gestational diabetes and severe preeclampsia.

MedDRA releases: 2024-11 · check-in free text available
2022-01-18
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-01-19
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-15	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-18	Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-17

Symptoms: Had rhinovirus (lasted 9 days), resolved. Been trying to conceive unsuccessfully for last 3 months.

Release 10 — 12 months, dose 2

2022-01-18

Symptoms: Pregnancy, delivered at 34 weeks on 12/1/21. Complicated by gestational diabetes and severe preeclampsia.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Complication of pregnancy	·	·	✓
SD	Gestational diabetes	·	·	✓
SD	Infertility	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Premature delivery	·	·	✓
SD	Rhinovirus infection	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release